263 related articles for article (PubMed ID: 11303295)
21. Sirolimus in pediatric patients: results in the first 6 months post-renal transplant.
Hymes LC; Warshaw BL
Pediatr Transplant; 2005 Aug; 9(4):520-2. PubMed ID: 16048606
[TBL] [Abstract][Full Text] [Related]
22. Sirolimus as primary immunosuppressant for calcineurin inhibitor-related renal insufficiency after liver transplantation.
Yang YJ; Li LX; He Q; Fan H; Jin ZK; Lang R; Kou JT; Li P; Xie DH; Chen DZ
Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):376-8. PubMed ID: 17690032
[TBL] [Abstract][Full Text] [Related]
23. Thymoglobulin, sirolimus, and reduced-dose cyclosporine provides excellent rejection prophylaxis for pancreas transplantation.
Knight RJ; Kerman RH; Zela S; Podder H; Van Buren CT; Katz S; Kahan BD
Transplantation; 2003 Apr; 75(8):1301-6. PubMed ID: 12717220
[TBL] [Abstract][Full Text] [Related]
24. Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients.
Trotter JF; Stolpman N; Wachs M; Bak T; Kugelmas M; Kam I; Everson GT
Liver Transpl; 2002 Mar; 8(3):212-8. PubMed ID: 11910565
[TBL] [Abstract][Full Text] [Related]
25. Primary immunosuppression regimen of rapid steroid withdrawal after living related liver transplantation: a single-center experience.
Toyoki Y; Hakamada K; Narumi S; Totsuka E; Nara M; Ono H; Ishizawa Y; Sasaki M
Transplant Proc; 2004 Oct; 36(8):2279-81. PubMed ID: 15561218
[TBL] [Abstract][Full Text] [Related]
26. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P
Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
[TBL] [Abstract][Full Text] [Related]
27. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
[TBL] [Abstract][Full Text] [Related]
28. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus.
Fairbanks KD; Eustace JA; Fine D; Thuluvath PJ
Liver Transpl; 2003 Oct; 9(10):1079-85. PubMed ID: 14526403
[TBL] [Abstract][Full Text] [Related]
29. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
Sundberg AK; Rohr MS; Hartmann EL; Adams PL; Stratta RJ
Clin Transplant; 2004; 18 Suppl 12():61-6. PubMed ID: 15217410
[TBL] [Abstract][Full Text] [Related]
30. Rejection episodes and 3-year graft survival under sirolimus and tacrolimus treatment after adult intestinal transplantation.
Lauro A; Dazzi A; Ercolani G; Zanfi C; Golfieri L; Amaduzzi A; Cucchetti A; La Barba G; Grazi GL; D'Errico A; Vivarelli M; Cescon M; Varotti G; Del Gaudio M; Ravaioli M; Di Simone M; Faenza S; Pironi L; Pinna AD
Transplant Proc; 2007 Jun; 39(5):1629-31. PubMed ID: 17580204
[TBL] [Abstract][Full Text] [Related]
31. Improvement in renal function and rejection control in pediatric liver transplant recipients with the introduction of sirolimus.
Casas-Melley AT; Falkenstein KP; Flynn LM; Ziegler VL; Dunn SP
Pediatr Transplant; 2004 Aug; 8(4):362-6. PubMed ID: 15265163
[TBL] [Abstract][Full Text] [Related]
32. Sirolimus (rapamycin) reduces the incidence of acute rejection episodes in renal transplantation: an initial experience in Taiwan.
Liu KL; Chu SH; Chiang YJ; Wu CT; Chen Y
Transplant Proc; 2004 Sep; 36(7):2051-2. PubMed ID: 15518742
[TBL] [Abstract][Full Text] [Related]
33. Tacrolimus dosing requirements and concentrations in adult living donor liver transplant recipients.
Taber DJ; Dupuis RE; Fann AL; Andreoni KA; Gerber DA; Fair JH; Johnson MW; Shrestha R
Liver Transpl; 2002 Mar; 8(3):219-23. PubMed ID: 11910566
[TBL] [Abstract][Full Text] [Related]
34. Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease.
Couriel DR; Saliba R; Escalón MP; Hsu Y; Ghosh S; Ippoliti C; Hicks K; Donato M; Giralt S; Khouri IF; Hosing C; de Lima MJ; Andersson B; Neumann J; Champlin R
Br J Haematol; 2005 Aug; 130(3):409-17. PubMed ID: 16042691
[TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up of immunosuppressive monotherapy in liver transplantation: tacrolimus and microemulsified cyclosporin.
Cholongitas E; Shusang V; Germani G; Tsochatzis E; Raimondo ML; Marelli L; Senzolo M; Davidson BR; Patch D; Rolles K; Burroughs AK
Clin Transplant; 2011; 25(4):614-24. PubMed ID: 20718824
[TBL] [Abstract][Full Text] [Related]
36. Steroid withdrawal five days after renal transplantation allows for the prevention of wound-healing complications associated with sirolimus therapy.
Sandrini S; Setti G; Bossini N; Maffei C; Iovinella L; Tognazzi N; Maffeis R; Nodari F; Portolani N; Cancarini G
Clin Transplant; 2009; 23(1):16-22. PubMed ID: 18727661
[TBL] [Abstract][Full Text] [Related]
37. FK 506 rescue therapy for hepatic allograft rejection: experience with an aggressive approach.
Woodle ES; Perdrizet GA; So SK; White HM; Marsh JW
Clin Transplant; 1995 Feb; 9(1):45-52. PubMed ID: 7537988
[TBL] [Abstract][Full Text] [Related]
38. Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation.
Pedrosa MC; Rohrer RM; Kaplan MM
Clin Transplant; 1995 Aug; 9(4):322-5. PubMed ID: 7579741
[TBL] [Abstract][Full Text] [Related]
39. Immunosuppressive efficacy of vincristine in heart transplantation: a preliminary report.
Gilbert EM; Renlund DG; O'Connell JB; Eiswirth CC; Rothstein G; Gay WA; Bristow MR
J Heart Transplant; 1987; 6(6):369-74. PubMed ID: 3320307
[TBL] [Abstract][Full Text] [Related]
40. [Indication for the steroid therapy for acute rejection].
Tanaka T; Suzuki K; Tsugawa R
Hinyokika Kiyo; 1998 May; 44(5):359-63. PubMed ID: 9656110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
